"recommendations of the Advisory Committee on Immunization Practices (ACIP)."
Mort Zuckerman
emcsw...@niaid.nih.gov, afa...@niaid.nih.gov,
Spin...@yahoogroups.com, kshe...@calea.org, fit...@gmail.com,
patrick.f...@usdoj.gov, model...@sbcglobal.net,
jdr...@nejm.org, let...@courant.com, Jgerb...@cdc.gov,
michae...@po.state.ct.us, con...@po.state.ct.us, executive-
edi...@nytimes.com, managin...@nytimes.com, news-
ti...@nytimes.com, the-...@nytimes.com, biz...@nytimes.com,
for...@nytimes.com, nati...@nytimes.com, dv...@cdc.gov,
brigidc...@optonline.net, tr...@hotmail.com, illino...@aol.com,
jle...@courant.com, tinaj...@yahoo.com, jhorn...@fff.org,
thomas...@usdoj.gov, thoma...@po.state.ct.us,
kur...@washpost.com, georg...@washpost.com, p...@allegorypress.com,
commissi...@po.state.ct.us, brans...@comcast.net,
vts...@comcast.net, o...@po.state.ct.us, freet...@charter.net,
scott....@po.state.ct.us, govern...@po.state.ct.us,
attorney...@po.state.ct.us, randall...@usdoj.gov,
Robert....@yale.edu
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, afa...@niaid.nih.gov,
bmi...@newstimes.com, tr...@hotmail.com, rast...@aol.com,
billc...@gmail.com, amcg...@rms-law.com, rjmu...@aol.com,
paulcrai...@yahoo.com, sidney_b...@yahoo.com,
criminal...@usdoj.gov, karla.d...@usdoj.gov,
christophe...@usdoj.gov, richar...@yale.edu,
harol...@yale.edu, james.p...@yale.edu, inq...@aldf.com,
ly...@idsociety.org
Subject: "recommendations of the Advisory Committee on Immunization
Practices (ACIP)."
Date: Feb 12, 2009 1:19 PM
Children should be pre-screened for immune status
before being given any vaccines. They give immune
compromised children fully heat-killed and not
attenuated viruses, but they - the CDC - never tell
parents that their kids should be pre-screened for their
immune status. This is something we learned from the
LYMErix/HIV/Tuberculosis vaccines fiascoes.
LYMErix caused the immune suppression that
chronic Lyme causes, due to the blebbing.
http://www.actionlyme.org/BARBOURS_STEALTH_BOMBERS.htm
Says CDC officer Alan Barbour:
"It's using some sort of stealth-bomber-type mechanism," he says. Or,
using another diversionary tactic called blebbing, the spirochete can
pinch off bits of its membrane in order to release its surface
proteins. Explains Barbour: "It's like a bacterial Star Wars defense
program," in which released surface proteins might intercept
incoming host antibodies, keeping the spirochete safe from
immunological attack.
^^^ AUTOVACCINATION WITH PAM3CYS
The blebbing is like autovaccination with LYMErix
or OspA or Pam3Cys.
http://www.actionlyme.org/PAM3CYS_IMMUNE_SUPPRESSION.htm
Ask Anthony Fauci aboudit:
http://content.nejm.org/cgi/content/full/359/9/888
Kathleen M. Dickson
http://www.actionlyme.org
===========================================
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=9639369[uid]
Measles, mumps, and rubella--vaccine use and strategies for
elimination of measles, rubella, and congenital rubella syndrome and
control of mumps: recommendations of the Advisory Committee on
Immunization Practices (ACIP).
Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L. MMWR Recomm
Rep. 1998 May 22;47(RR-8):1-57.
These revised recommendations of the Advisory Committee on
Immunization Practices (ACIP) on measles, mumps, and rubella
prevention supersede recommendations published in 1989 and 1990. This
statement summarizes the goals and current strategies for measles,
rubella, and congenital rubella syndrome (CRS) elimination and for
mumps reduction in the United States. Changes from previous
recommendations include: Emphasis on the use of combined MMR vaccine
for most indications; A change in the recommended age for routine
vaccination to 12-15 months for the first dose of MMR, and to 4-6
years for the second dose of MMR; A recommendation that all states
take immediate steps to implement a two dose MMR requirement for
school entry and any additional measures needed to ensure that all
school-aged children are vaccinated with two doses of MMR by 2001; A
clarification of the role of serologic screening to determine
immunity; A change in the criteria for determining acceptable evidence
of rubella immunity; A recommendation that all persons who work in
health-care facilities have acceptable evidence of measles and rubella
immunity; Changes in the recommended interval between administration
of immune globulin and measles vaccination; and *** Updated
information on adverse events and contraindications, particularly for
persons with severe HIV infection, persons with a history of egg
allergy or gelatin allergy, persons with a history of
thrombocytopenia, and persons receiving steroid therapy.***